Brian Muir
Family Medicine · Rupert, IDNPI 1386872810
Payments from drug & device makers
Across 97 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$356
- AstraZeneca$220
- Novo Nordisk$151
- Comsort, Inc$150
- Novartis$143
- Boehringer Ingelheim$111
- plus $786 from 18 others
What the payments were for
- Consulting fees$1508%
- Food & beverage$1,76892%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 16 | $356 |
| AstraZeneca | 8 | $220 |
| Novo Nordisk | 10 | $151 |
| Comsort, Inc | 1 | $150 |
| Novartis | 8 | $143 |
| Boehringer Ingelheim | 6 | $111 |
| Boston Scientific | 3 | $103 |
| Astellas Pharma US Inc | 3 | $89 |
| Exact Sciences | 5 | $83 |
| Bayer | 5 | $81 |
| Amgen | 6 | $77 |
| Lilly USA, LLC | 5 | $63 |
| GSK | 4 | $56 |
| Merck | 4 | $38 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| Dexcom, Inc. | 2 | $31 |
| Pfizer | 2 | $25 |
| Johnson & Johnson | 2 | $23 |
| Radius Health, Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Corium, LLC | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,918 in reported general payments places this provider in the 80th percentile of 803 family medicine providers in Idaho.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 74 | $72,094 |
| EliquisApixaban | 37 | $38,818 |
| TrulicityDulaglutide | 26 | $25,571 |
| MounjaroTirzepatide | 23 | $23,454 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 31 | $21,981 |
| FarxigaDapagliflozin Propanediol | 19 | $17,453 |
| JardianceEmpagliflozin | 22 | $13,078 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 45 | $6,923 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $4,516 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 13 | $3,474 |
| Levothyroxine Sodium | 267 | $3,349 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 43 | $2,799 |
| Gabapentin | 193 | $2,724 |
| Tolterodine Tartrate ErTolterodine Tartrate | 19 | $2,574 |
| Rosuvastatin Calcium | 297 | $2,286 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $151 | $72,09474 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $63 | $49,02549 claims |
| PfizerEliquis | $25 | $38,81837 claims |
| GSKTrelegy Ellipta | $56 | $21,98131 claims |
| AstraZenecaFarxiga | $220 | $17,45319 claims |
| Boehringer IngelheimJardiance | $111 | $13,07822 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 803 family medicine providers in Idaho.
Other family medicine in Rupert
- Mark TurnerMeridian$40.5M
- David ButukMeridian$15.2M
- Gary SoucieBlackfoot$5.8M
- Brock McConneheyBoise$4.5M
- William LaitinenMiddleton$1.1M
- Diane McConneheyBoise$681K
- Flint PackerIdaho Falls$587K
- Paul BeckettBlackfoot$344K
- Elaine DavidsonMeridian$303K
- Kenneth CongerSandpoint$266K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.